Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial
Conditions: Lung Carcinoma Interventions: Other: Electronic Health Record Review; Other: Interview; Behavioral: Patient Navigation Sponsors: Fred Hutchinson Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Oropharyngeal Squamous Cell Carcinoma Interventions: Procedure: Biospecimen Collection; Drug: Carboplatin; Drug: Cisplatin; Procedure: Computed Tomography; Radiation: External Beam Radiation Therapy; Drug: Paclitaxel; Procedure: Positron Emission Tomography; Other: Questionnaire Administration Sponsors: Ohio State University Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma; Anti-PD1/PDL1 Antibody; Bevacizumab Interventions: Procedure: Locoregional therapy; Drug: Bevacizumab; Drug: Atezolizumab; Drug: Tislelizumab; Drug: Toripalimab; Drug: Sintilimab; Drug: Camrelizumab Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Tislelizumab （neoadjuvant）; Drug: Cisplatin （neoadjuvant）; Drug: Nab-paclitaxel （neoadjuvant）; Procedure: Surgical resection; Drug: Cisplatin（adjuvant）; Drug: Tislelizumab（adjuvant）; Radiation: Radiation; Drug: Carboplatin（neoadjuvant）; Drug: Carboplatin（adjuvant） Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma
Conditions: Adenoid Cystic Carcinoma Interventions: Drug: 177Lu-PNT2002 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Adenoid Cystic Carcinoma Research Foundation; Progenics Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma Metastatic Interventions: Drug: JMKX003948 Sponsors: Jemincare; Zhejiang Hangyu Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Herpesvirus 4, Human Interventions: Diagnostic Test: EBV-DNA next generation sequencing Sponsors: Hunan Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Conditions: HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Two IM injections Lenti-HPV-07; Drug: One IM injection Lenti-HPV-07 Sponsors: Theravectys S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Conditions: Oral Squamous Cell Carcinoma; Oral Potentially Malignant Disorder; Oral Leukoplakia; Proliferative Verrucous Leukoplakia; Oral Lichen Planus; Oral Lichenoid Lesion; Graft-versus-host-disease; Oral Erythroplakia; Actinic Keratoses; Actinic Cheilitis; Oral Cancer; Oral Disease Interventions: Device: OCT (Optical Coherence Tomography) Sponsors: University of Palermo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Recurrent Ovary Cancer; Ovarian Cancer; Ovarian Carcinoma; Ovarian Carcinoma, Recurrent Interventions: Biological: Cytokine-Induced Memory-like Natural Killer Cells; Biological: IL-15 Superagonist Sponsors: Dana-Farber Cancer Institute; ImmunityBio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach
Conditions: HPV-Related Carcinoma Interventions: Radiation: Radiation therapy as curative treatment Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: TQB2223 injection; Drug: Penpulimab Injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Conditions: Breast Cancer; Lung Cancer; Melanoma; Head and Neck Cancer; Urothelial Carcinoma; Colorectal Cancer; Liver Metastases; Lung Metastases Interventions: Genetic: Cohort A: primarily operable disease, candidate to adjuvant; Genetic: Cohort B: locally advanced disease; Genetic: Cohort C: metastatic disease; Genetic: Cohort D: Progressive disease; Genetic: Cohort E: Hematological neoplasms; Genetic: Cohort F: Toxicity Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS
Conditions: Hepatocellular Carcinoma; Circulating Tumor Cell; Recurrence; Surgery Interventions: Diagnostic Test: circulating tumor cells Sponsors: Zhujiang Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
Conditions: Papillary Thyroid Cancer Interventions: Procedure: thyroid surgery; Procedure: ultrasound-guided thermal ablation Sponsors: Chinese PLA General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
